logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover
CMND
Clearmind Medicine Inc.
1.96
1 x 1.76
1 x 2.17
bid
ask
+
0.07
3.70%
61 @ 04:00 PM
1.94 -0.02 (1.02%)
Ytd-89.17%
1y-99.52%
1.84
day range
2.31
1.43
52 week range
524.00
Open1.96Prev Close1.89Low1.84High2.31Mkt Cap2.91M
Vol797.91KAvg Vol1.92MEPS-24.50P/E-0.08Forward P/EN/A
Beta-1.51Short Ratio1.88Inst. Own16.02%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg2.20200-d Avg29.181yr Est0.00

CMND News

Clearmind Medicine Makes Clinical Progress in Alcohol Addiction Treatment Trial
benzinga.com
Clearmind Medicine Makes Clinical Progress in Alcohol Addiction Treatment Trial

The independent Data and Safety Monitoring Board on Thursday unanimously approved Clearmind Medicine

Clearmind Advances CMND-100 to Alcohol Use Disorder Patients After Achieving Primary Safety Endpoint
globenewswire.com
Clearmind Advances CMND-100 to Alcohol Use Disorder Patients After Achieving Primary Safety Endpoint

Clearmind Medicine has received Independent Data and Safety Monitoring Board (DSMB) approval to adva

Clearmind Medicine Announces Positive Permeation Results for Intranasal MEAI Formulation, Supporting Enhanced Nasal Retention Without Compromising Drug Delivery
globenewswire.com
Clearmind Medicine Announces Positive Permeation Results for Intranasal MEAI Formulation, Supporting

Vancouver, Canada, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND, FSE: CWY

Clearmind Reaches Key Clinical Trial Milestone as DSMB Unanimously Clears Progression in AUD Study
globenewswire.com
Clearmind Reaches Key Clinical Trial Milestone as DSMB Unanimously Clears Progression in AUD Study

Clearmind Medicine has received Independent Data and Safety Monitoring Board (DSMB) approval to adva

Clearmind Medicine Signs Letter of Intent to Acquire 51% Majority Stake in EV Wireless Charging Solutions for Automated Parking Systems Company
globenewswire.com
Clearmind Medicine Signs Letter of Intent to Acquire 51% Majority Stake in EV Wireless Charging Solu

Vancouver, Canada, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearm

Clearmind Announces Positive Safety Findings for CMND 100, Demonstrating Consistent Tolerability Throughout Full Dose Escalation in Part A of its FDA-Regulated Clinical Trial
globenewswire.com
Clearmind Announces Positive Safety Findings for CMND 100, Demonstrating Consistent Tolerability Thr

Vancouver, Canada, July 30, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), a clini

Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial
globenewswire.com
Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial

Vancouver, Canada, July 28, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (“Clearmind” or “Compan
benzinga.com
Clearmind Medicine Files Hong Kong Patent Application For Innovative Psychedelic Compounds For Treat

The Hong Kong patent application forms part of Clearmind’s exclusive worldwide licensing agreement w

Clearmind Medicine Expends Global IP portfolio with Hong Kong Patent Filing for Novel Psychedelic Compounds; Targets Multi‑Billion‑Dollar PTSD Therapeutics Market
globenewswire.com
Clearmind Medicine Expends Global IP portfolio with Hong Kong Patent Filing for Novel Psychedelic Co

Vancouver, Canada, July 20, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. ("Clearmind") (Nasdaq:

Clearmind Medicine Commends Federal Momentum in Advancing Psychedelic-Based Therapies for Mental Health and Addiction
globenewswire.com
Clearmind Medicine Commends Federal Momentum in Advancing Psychedelic-Based Therapies for Mental Hea

Vancouver, Canada, July 17, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), a clini

Clearmind Medicine Reports Positive Retention Results for Intranasal Formulation of its Psychedelic-Based Neuroplastogen MEAI
globenewswire.com
Clearmind Medicine Reports Positive Retention Results for Intranasal Formulation of its Psychedelic-

Vancouver, Canada, July 16, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), a clini

Clearmind Shares Promising Real-World Insights from Ongoing CMND-100 First-in-Human Trial
globenewswire.com
Clearmind Shares Promising Real-World Insights from Ongoing CMND-100 First-in-Human Trial

Principal Investigators of the Ongoing Phase I/II a Trial Highlighted Positive Early Experience with

Clearmind Medicine Responds to the U.S. Administration’s RFI for Addiction Treatment Innovations as Part of the Great American Recovery Initiative
globenewswire.com
Clearmind Medicine Responds to the U.S. Administration’s RFI for Addiction Treatment Innovations as

Vancouver, Canada, July 10, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), a clini

Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration Development for MEAI
globenewswire.com
Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route

Vancouver, Canada, July 07, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), a clini

Clearmind Medicine Advances Its Innovation with Newly Granted U.S. Patent, Enhancing Global Patent Strength
globenewswire.com
Clearmind Medicine Advances Its Innovation with Newly Granted U.S. Patent, Enhancing Global Patent S

Vancouver, Canada, June 29, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) ("Clearm

Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial
globenewswire.com
Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II

Vancouver, Canada, June 22, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) ("Clearm

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Why Taylor Morrison Home Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Taylor Morrison Home Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Taylor Morrison Home soared 23.28% to $72.12 in pre-market trading after Berkshire Hathaway announce

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

Gold Falls 1%; Amer Sports Earnings Top Views
benzinga.com
Gold Falls 1%; Amer Sports Earnings Top Views

US stocks down, Nasdaq drops 200 points. Dow -0.35% at 49,512.48, Nasdaq -0.93% at 25,849.08, S&

Dow Falls Over 100 Points; Home Depot Posts Upbeat Earnings
benzinga.com
Dow Falls Over 100 Points; Home Depot Posts Upbeat Earnings

US stocks fall, Dow Jones down 0.34% & NASDAQ down 0.41% in morning trading. Home Depot reports

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Why LightPath Technologies Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why LightPath Technologies Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-D

Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarte
benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 469 companies hit new 52-week lows.